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Cognitive behavioral therapy (CBT-I) is a common and effective method for treating chronic 
insomnia, although patient responses to it are not uniform and research on predicting treatment 
response has mostly focused on psychological factors. Here, it is investigated whether brain 
oscillations during sleep at baseline, particularly sleep spindles, are predictive of treatment 
response. Twenty-four participants with chronic primary insomnia took part in a 6-week CBT-I 
performed in groups of 4 to 6 participants. Treatment response to CBT-I was assessed using the 
Pittsburgh Sleep Quality Index (PSQI) and the Insomnia Severity Index (ISI) measured at pre- 
and post-treatment. Secondary outcome measures included sleep diary (over seven days) and 
polysomnography (PSG) sleep efficiency (%) measured at pre- and post-treatment. Spindle 
density (as well as secondary measures of duration, amplitude, power, frequency, and spectral 
power in the sigma band) during stages N2-N3 sleep were extracted from the PSG recording at 
pre-treatment. Multiple regression assessed whether sleep spindle activity predicted treatment 
response to CBT-I. After controlling for baseline measures, age, sex, education level, treatment 
compliance, time in N2, and the location of the sleep recording, lower spindle density and sigma 
power at pre-treatment predicted poorer CBT-I response at post-treatment, as reflected by lower  
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 Insomnia is one of the most commonly reported sleep disturbances with an estimated 6-
10% of adults meeting clinical criteria for an insomnia disorder, leading to health consequences 
and impairments in quality of life.
1, 2
 Similar prevalence rates have also been noted in university 
students with around 9.5% meeting clinical criteria for chronic insomnia in one study.
3
 Chronic 
insomnia is characterized by subjective reports of poor sleep quality related to one or more 
symptoms of: difficulty falling asleep, difficulty maintaining sleep and/or early morning 
awakenings with the inability to fall back asleep, despite adequate opportunity to sleep. These 
symptoms must persist for at least three months with sleep disturbances occurring three times a 
week or more, and must be related to impairments in daytime functioning.
4
 Daytime impairments 
may include fatigue, sleepiness, problems with attention and memory, mood disturbances, 
reduced energy and motivation, and physiological effects such as headaches and gastrointestinal 
problems. Insomnia can broadly be conceptualized as either a primary condition, occurring in the 
absence of other medical or psychiatric problems, or a secondary condition occurring comorbid 
with another disorder or linked to an external cause (such as medication). Insomnia may be 
caused by other undiagnosed sleep disorders (such as sleep apnea), is often reported with 
psychiatric problems such as depression and anxiety, and is associated with medical conditions 
including heart disease and chronic pain.
2
 As well, certain prescription, over-the-counter, and 
recreational drugs can cause sleep problems and either induce or exacerbate insomnia symptoms. 
It is therefore important when assessing insomnia complaints to identify whether any underlying 
factors or comorbidities may be relevant and design a treatment plan accordingly.    
 Insomnia symptoms often have a severe impact on quality of life and can lead to an 
increased risk of accidents, decreased work productivity and absenteeism.
5





prevalence as well as the cost of treatments and impact on work productivity, it also leads to a 
severe economic burden both on the individual suffers and society. In Quebec, the total annual 
cost of insomnia was estimated to be $6.6 billion with $5 billion of that being productivity losses 
related to insomnia.
6
 It is therefore imperative that insomnia is better understood, especially in 
regards to improving treatment efficacy. 
 Insomnia is primarily treated through two means: pharmacological interventions and 
cognitive behavioral therapy for insomnia (CBT-I).
2
 Pharmacological treatment is commonly 
used due to its ease and availability and is most often hypnotic agents such as benzodiazepines or 
other benzodiazepine receptor agonists, although antidepressants, anticonvulsants, 
antipsychotics, and melatonin receptor agonists are also used. The drawbacks to this form of 
treatment are drug side effects most commonly including dizziness, drowsiness, lightheadedness, 
amnesia and gastrointestinal problems, as well as the development of tolerance and dependence 
which can lead to misuse.
2
 This raises the question of the long-term efficacy of pharmacological 
interventions. Although some studies support the long-term benefits of hypnotic treatments,
7, 8
 
most indicate a short-term improvement with long-term improvements being associated with 
behavioral intervention such as CBT-I.
9-11
 It is likely then that acute bouts of insomnia may be 
best addressed with pharmacological intervention while long lasting chronic insomnia may be 
better addressed by CBT-I.
12
 
 Cognitive behavioral therapy for insomnia (CBT-I) is a multimodal approach including 
an array of components aimed at addressing both poor sleep habits and behavior as well as 
dysfunctional beliefs about sleep. These components include stimulus control, sleep restriction, 
sleep hygiene, cognitive restructuring and relaxation techniques.
13
 Stimulus control seeks to 





means avoiding all non-sleep activities while in bed, such as reading or watching TV (sex being 
the only exception), as well as leaving the bedroom if one is having difficulty falling asleep in 
order to avoid associating the bed with anxiety about sleep difficulties. Sleep restriction aims to 
consolidate sleep by limiting time in bed and creating a consistent sleep-wake schedule. 
Insomniacs often spend excessive amounts of time in bed trying to sleep which leads to 
inconsistent and fragmented sleep patterns. Sleep restriction attempts to undo this habit by at first 
inducing some partial sleep deprivation through restriction, which in turn leads to a greater 
homeostatic sleep drive in subsequent nights, and eventually more consolidated sleep as a whole. 
Sleep hygiene focuses on education about sleep and improvement in sleep-related behaviors. 
This consists of teaching basic knowledge about the process and functions of sleep itself as well 
as behavioral changes to improve sleep such as not having a visible clock near your bed. 
Cognitive restructuring attempts to address dysfunctional beliefs insomniacs may have about 
sleep. These beliefs may include unrealistic expectations about sleep, such as the idea that it is 
absolutely necessary to have 8 hours of sleep, or faulty beliefs about the causes or cures for 
insomnia, such as the idea that insomnia is caused purely by chemical imbalances that can only 
be treated with sleep medication. Relaxation techniques, such as meditation or progressive 
muscle relaxation, are also often taught to reduce arousal and anxiety related to sleep. CBT-I 
may be administered individually or in a group setting and can vary in terms of the length of the 
course of treatment and the components used. Overall, CBT-I has well documented efficacy
14, 15
 
with treatment response rates around 60-70% and remission rates around 40%.
16, 17
 Its primary 
advantages over pharmacological interventions are the absence of drug-related side effects and 






 Although the efficacy of CBT-I is robustly supported, not all patients respond to therapy. 
As with interventions for other psychiatric disorders, inter-individual differences can play a role 
in treatment response.
18
 Already, inter-individual differences have shown to be important risk 
factors for developing insomnia with individuals of poor general health, poor mental health, and 
prone to increased stress reactivity and hyperarousal being at higher risk.
19-21
 It is possible that 
inter-individual differences within the population of insomniacs may as well be predictive of 
response to CBT-I and account for differences in treatment outcomes. 
 Previous research on predicting treatment outcomes for CBT-I has produced mixed 
results implicating a number of different possible individual factors. Personality traits have 
shown to be predictive with a study of elderly insomniacs finding those who were more 
traditional, conventional and rigid showing better improvements in sleep duration after therapy.
22
 
Greater baseline insomnia severity has also been demonstrated to predict better treatment 
response, although this is not consistent across all studies.
23-28
 Similarly, those with greater 
dysfunctional beliefs about sleep at baseline showed more improvement post therapy than those 
with less pronounced belifs
29
, although not in all studies.
24
 Higher levels of depression and 
anxiety were also found to be predictive of better CBT-I response
23
, although again this effect 
was inconsistent and not found in several studies.
30, 31
 Another factor common to all 
psychological interventions that have shown to be predictive for CBT-I is the quality of the 
therapeutic alliance, particularly based on the initial expectations insomniacs had of the therapy 
outcome.
32
 Those with low pre-treatment expectations but perceiving the therapist to have a 
higher affiliation showed the most improvement while those who perceived the therapist as 
critically confrontational reported less treatment satisfaction and were more likely to drop out of 
the therapy.
32





implementing behavioral changes, and actively engaging in the therapeutic process has been 
shown to be related to treatment success.
33
  
 One area that has not received much attention is examining sleep micro-architecture at 
baseline as a predictor. Briefly, the architecture of sleep in humans has been classified by 
electroencephalographic (EEG) recordings of sleeping subjects with stages of sleep being 
categorized by various aspects of the recorded waveforms as well as recordings of eye 
movements and muscle tone. Broadly, sleep is divided into two main types: non-rapid-eye-
movement (NREM) sleep and rapid-eye-movement (REM) or paradoxical sleep. NREM sleep is 
divided into three stages, which are characterized by increasing synchrony of neural oscillations, 
observed as high amplitude, low-frequency waveforms. Stage one NREM represents an 
intermediary stage between wakefulness and sleep characterized by the transition of the alpha 
rhythm (8-13 Hz) to the theta rhythm (4-7 Hz) as the individual proceeds into stage two NREM. 
Stage two is the most prominent stage of sleep in adult humans constituting around half of total 
sleep and is identified primarily by the appearance of transient EEG events: sleep spindles and 
K-complexes. As sleep deepens and stage three NREM is entered, the EEG is characterized by 
high amplitude, low-frequency delta waves (0.5-4 Hz), lending the name slow wave sleep. 
Conversely, REM sleep is identified by its high frequency, low amplitude EEG activity, often 
resembling that of waking, along with rapid eye movements and a reduced muscle tone. The only 
previous study to examine EEG measures as a predictor of treatment response showed that lower 
EEG delta power in the first NREM sleep cycle at baseline predicts better response to CBT-I.
34
 
Another component of sleep architecture that may be of interest in this area are sleep spindles. 
 Sleep spindles are transient oscillations of around 12-14 Hz (sigma band) seen in EEG 





interplay of thalamic and cortical neurons.
35
 Functionally, spindles have been associated with the 
retention of memory traces overnight as well as cognitive abilities.
36-40
 For example, after a 
declarative learning task spindle density during sleep was found to be increased compared to a 
control task and was highly correlated with recall performance.
36
 Of more specific interest to 
insomnia, spindles have also been shown to be related to the gating of external stimuli, 
particularly acoustic, during sleep, and may more broadly be related to sleep stability. One of the 
earliest studies to demonstrate a causal relationship between spindles and sleep quality was a 
study in cats, which used an instrumental conditioning task to increase the sensorimotor rhythm 
(SMR), an EEG oscillation recorded predominately over the sensorimotor cortex in waking with 
a range of around 12-15 Hz (similar to that of spindles). It was found that reinforcing the SMR 
during wake led to an increase in spindle activity during sleep as well as longer epochs of 
undisturbed sleep.
41
 More recent animal studies have further supported this relationship. 
Transgenic mice over expressing an ion channel related to spindle generation displayed less 
fragmented NREM sleep and a higher auditory arousal threshold than wild types when 
sleeping.
42
 Similarly, using optogenetic stimulation of the thalamic reticular nucleus to induce 
spindles in mice lead to an increase in both spindle density and NREM sleep duration. Studies in 
humans have found similar results but are limited by the difficulty in experimentally 
manipulating spindles in humans.  Combined EEG-fMRI studies have shown that sounds played 
during sleep will consistently activate the auditory cortex except when the sound occurs during 
spindles.
43, 44
 Further, individuals with lower spindle densities were shown to be more likely  
aroused from sleep when sounds (such as traffic noise or a telephone ringing) were played during 
sleep than those with higher spindle densities.
45





spindles serve as a sleep protective mechanism that may help maintain sleep in the face of noise, 
and may be related to the overall stability of NREM sleep.  
 It is therefore plausible that differences in spindles may be related to the lower quality 
and often fragmented sleep seen in chronic insomnia. There is a great deal of inter-individual 
differences in sleep spindle measures. The earliest studies on this indicated that spindle density 
could vary greatly from one individual to another, but importantly remained stable and consistent 
across multiple nights in each individual.
46, 47
 Later research also found stable individual 
differences in spindle EEG frequencies, even going so far as to refer to this as an "EEG 
fingerprint".
48, 49
 These findings point to spindles being a stable, individual trait. Individual 
differences in spindle activity are most often quantified by differences in spindle density. This 
measure is particularly useful and common in spindle research as it is a measure of the average 
number of spindles per given time period (usually per 30 sec or 1 min) of NREM sleep (or 
another sleep stage of interest) and therefore is less dependent on  NREM sleep duration (or 
another sleep stage of interest) than the absolute number of spindles. Spindles can be measured 









, or spectral power in the sigma band
49-51
 (the EEG band of spindles) but 
density is the most robustly studied and consistently used in previous literature, particularly in 
identifying differences in spindle activity between individuals. 
 It may be the case that spindle differences at the individual level represent a predisposing 
factor to insomnia. This was demonstrated in a longitudinal academic stress study in which 
university students completed an insomnia questionnaire and had a night of sleep recorded at the 
beginning of the academic semester and later filled out the same questionnaire at the end of the 





sleep cycle and lower spindle amplitude in the first and third sleep cycles  as well as lower 
spectral sigma power at the beginning of the semester prospectively reported a greater increase in 
insomnia symptoms in response to the stress of exams at the end of the semester.
50
 This suggests 
an association between lower spindle characteristics  and the development of insomnia 
symptoms in response to stress. This finding contrasts with the absence of reported difference in 
number and density of spindles between insomniacs and good sleepers at the group level.
52
 Such 
absence of group differences does not exclude the possibility of a subgroup of insomniacs in 
which spindle characteristics may perpetuate sleep problems. This is supported by the 
observation that chronic insomnia is not a homogenous disorder in how it develops and presents 
among sufferers, but rather that there are multiple sub-types
53
 likely with distinct etiologies, and 
differences in spindles may represent one of many possible factors related to the development of 
insomnia. Spindles as an innate neurophysiological risk factor also fit with one of the main 
overarching theories of insomnia that suggest insomniacs are in a state of hyperarousal.
54
 
Spindles are related to the gating of external stimuli so it is possible that a vulnerability to sleep 
disruption caused by lower spindles may contribute to this hyperarousal in some insomniacs, but 
not all. Since spindle measures constitute a trait, they will be unlikely to be modified with CBT-
I, and thus lower spindle characteristics in a subgroup of insomniacs might hinder the effects of 
CBT-I leading to differences in treatment response. Particularly, this hindrance could be related 
to the stimulus control and sleep hygiene components of CBT-I that seek to make the bedroom a 
quiet, relaxing environment associated with restful sleep. If spindles are related to overall sleep 
stability and the gating of external stimuli during sleep, then lower spindle activity may 





sleep, even with the best efforts of the insomnia sufferer to make the bedroom environment less 
stimulating and associate it with restful sleep.  
 The purpose of this study was to assess whether inter-individual differences in spindle 
measures prospectively predict response to CBT-I among chronic primary insomniacs. Spindle 
density was the main predictor of interest, although secondary analyses using spindle duration, 
amplitude, power, frequency, and sigma power as predictors were also carried out. As well, delta 
power was also tested to try to replicate previous results, that found that lower delta power in the 
first sleep cycle at baseline predicted better response to CBT-I.
34
 Primary outcomes of interest 
were changes in sleep and insomnia questionnaires (Pittsburgh Sleep Quality Index, PSQI; 
Insomnia Severity Index, ISI) from pre-treatment to post-treatment, and secondary outcomes 
were changes in sleep efficiency from sleep diaries and polysomnography (PSG; from baseline 
to  post-treatment). Changes in these variables were examined in relation to spindle measures at 
pre-treatment. We hypothesized that insomniacs with lower spindle activity would show poorer 
improvement in CBT-I outcomes, compared to those with higher spindle activity. 
METHOD 
Participants 
 Participants with chronic primary insomnia were recruited via online and print 
advertisements posted in the community as well as from physician referral. Prospective 
participants were initially screened over the phone for inclusion and exclusion criteria, followed 
by a semi-structured in-person medical interview to determine eligibility. Participants had to 
meet the ICSD-3 diagnostic criteria for chronic insomnia disorder, i.e. difficulty initiating sleep, 
difficulty maintaining sleep, and/or early morning awakenings, combined with daytime 







 Exclusion criteria were being less than 18 years of age, having major psychiatric or 
medical conditions including sleep disorders other than insomnia, recent shift work or changes in 
time zones over the past 2 months, and using recreational drugs or prescription drugs that might 
affect sleep. If currently taking sleep medication, participants were asked to stop that medication 
at least 1 week before the first PSG assessment and until the end of the post-treatment 
assessment. Participants subsequently underwent a PSG to rule out the presence of other sleep 
disorders contributing to insomnia symptoms, particularly sleep apnea (an apnea-hypopnea index 
> 5/h was an exclusion criterion). Out of 86 potential participants screened over the phone, a 
total of 49 completed the in-person semi-structured interview; 38 were deemed eligible and 29 
agreed to enter the study protocol. Of those, 2 dropped out midway through the CBT-I sessions 
for personal reasons, 2 completed the CBT-I sessions but dropped out before the post-treatment 
assessments, and 1 was excluded due to presenting persistent flu-like symptoms during the 
course of the CBT-I sessions (after completion of the study this participant was diagnosed with 
irritable bowel syndrome and attributed these symptoms to this). Unfortunately, data was only 
available for 2 of the 4 drop-outs. In total, 24 (19 females, 5 males; Mage = 42.84, SD = 15.7) 
participants completed the treatment and were included in the final analysis (See Table 1 for 
demographic and baseline sleep parameters). All participants signed an informed consent form 
before entering the study, which was approved by the Concordia University Human Research 
Ethics Committee. 
Procedure 
 After enough participants were deemed eligible following a PSG screening to form a 
treatment cohort (4-6 people), participants were scheduled for a second sleep recording night 





complete for one week and two questionnaires, the Pittsburgh Sleep Quality Index (PSQI)
56
 and 
the Insomnia Severity Index (ISI).
57
 Participants then completed six, weekly group sessions of 
CBT-I. Within a month of completion, participants were scheduled for a third sleep recording 
night and again given a sleep diary to complete for a week along with the two aforementioned 
questionnaires. Follow-ups were later conducted by phone 3 months and 1 year following CBT-I 
completion and consisted again of the same two questionnaires (see Fig. 1 for a schematic of the 
study procedure), although the focus of the analyses presented here is limited to the pre- to post-
treatment effects only. 
Self-reported sleep measures 
 Sleep quality and insomnia symptoms were assessed through standardized questionnaires 
and sleep diaries completed both before and after CBT-I. The first questionnaire used was the 
Pittsburgh Sleep Quality Index (PSQI), a self-report measure of general sleep quality over the 
past month. The PSQI consists of 7 sub-components (subjective sleep quality, sleep latency, 
sleep duration, habitual sleep efficiency, sleep disturbances, use of medication, and daytime 
dysfunction) calculated through 4 free response questions related to the timing of sleep habits 
and 6 Likert-style questions. PSQI scores fall on a scale from 0-21 (with higher scores indicating 
worse sleep quality) and have been shown to have an average of 10.38 (SD = 4.57) in insomniacs 
with an overall Cronbach α of 0.83.56 The second questionnaire used was the Insomnia Severity 
Index (ISI), a self-report measure of the nature, severity and impact of current insomnia 
symptoms. The ISI consists of 7 Likert-style questions with a total score ranging from 0-28 (with 
higher scores indicating more severe insomnia) and average reported in insomniacs of 19.7 (SD 
= 4.1) with an overall Cronbach α of 0.74.57 While all 24 participants completed these 





3 months. At 1 year, 19 participants completed both PSQI and ISI. PSQI and ISI scores were the 
primary outcome variables used to assess CBT-I responses. In addition to these questionnaires, 
sleep diaries based on the consensus sleep diary were given to the participants.
58
 They were 
administered only at pre- and post-treatment, for seven days at each assessment. Sleep efficiency 
(as defined by the ratio total sleep time/time in bed, in %) was extracted from sleep diaries by 
averaging daily values over seven days, including both weekends and weekdays. Sleep efficiency 
derived from sleep diaries was used as a secondary variable to assess response to CBT-I. Sleep 
diaries were fully completed by 22 out of the 24 participants. Also of interest as a possible 
predictor of treatment response was adherence to treatment measured from the Spousal Rated 
Adherence Questionnaire (SRAQ)
59
. This questionnaire was created specifically to measure 
adherence to the different components of CBT-I, originally to be done by a therapist or spouse 
but adapted in the present study as a self report questionnaire administered midway through the 
therapy sessions. 
Sleep recordings 
 Sleep recordings (PSG) were obtained at pre- and post-treatment. Participants completed 
three nights of PSG at the PERFORM Centre Sleep Laboratory at Concordia University. The 
first night served as an initial screening (for sleep apnea) and habituation night, while the second 
served as the baseline experimental night to provide sleep measures before CBT-I; they were 
conducted at least 3 days apart. The third PSG was performed within a month following the last 
CBT-I session. For a subset of participants (25%), PSG recordings were conducted at home 
(ambulatory mode) due to ongoing renovations of the sleep laboratory. Since these recordings 
were not conducted in a laboratory environment, there was no habituation night and those 6 





after CBT-I). Comparisons were made to ensure there were no relevant differences from these 
home recordings (see Results section). All PSG recordings (both in-lab and ambulatory) were 
performed using the same equipment and recording parameters: 34-channel Embla Titanium 
system (Natus Medical, San Carlos, CA, USA) with EEG referenced to linked mastoids 
(bandpass filter 0.3-100 Hz, sampling rate 512 Hz), electrooculography (EOG) and 
electromyography (EMG). Additionally, the first in-lab (habituation) and ambulatory PSG 
recordings included thoracic and abdominal respiration belts, nasal-oral thermocouple airflow, 
and transcutaneous finger pulse oximetry to allow for sleep apnea screening. All participants 
were asked to abstain from caffeine and alcohol on each day of PSG recording. Bedtime and 
awakening times were determined by the participant in accordance with their habitual sleep 
schedule.  
Sleep stages were scored according to standard criteria,
60
 and changes in sleep efficiency 
from baseline to post-CBT-I were calculated as a secondary outcome measure of treatment 
response. Sleep spindles were detected automatically during N2 and N3 stages of sleep from the 
C4-O2 derivation. This was chosen due to the prominent detection of spindles over central 
leads.
61
 The spindle detection method (Aseega software, Physip, Paris, France) was based on 
data-driven criteria using multiple iterations in order to cope with inter-subject and inter-
recording variability.
62
 It was based on an iterative approach. The first iteration aimed at 
determining recording-specific thresholds, based on EEG power ratios in delta, alpha and sigma 
bands. The second iteration provided precise temporal localization of the events. The final 
iteration enabled the validation of detected events based on frequency and duration criteria (> 
0.5s). Iteration 1 and 3 dealt with raw EEG data, while iteration 2 was applied on the EEG 





based on his/her global spectral profile (median values for low and high bands were 11.9 and 
15.9 Hz respectively; means values for low and high bands were 11.8 and 15.8 respectively). 
Spindles were quantified according to average density (number per 30 sec. epoch), duration (in 
seconds), power (in squared microvolts), amplitude (maximum, in microvolts), and frequency (in 
hertz). These spindle characteristics were computed for N2-N3 NREM sleep for the whole night. 
(See figures 2 and 3 for examples EEG traces of spindles taken from two participants)  After 
automatic EEG artifact rejection, EEG power in the adapted sigma frequency range during total 
N2-N3 NREM sleep was calculated using Hanning window and normalized to the global spectral 
power for each 30-sec. epoch. Average EEG sigma power was used as an additional measure of 
spindle activity. Likewise, EEG power in the delta frequency range (0.7-4Hz) was also 
calculated, both during total N2-N3 NREM sleep and during the first sleep cycle of N2-N3, 
because EEG delta power during the first NREM sleep cycle was previously shown to be a 
predictor of CBT-I treatment response.
34
  
Cognitive-behavioral therapy for insomnia (CBT-I) 
All participants underwent CBT-I following their baseline assessment. This treatment consisted 
of an empirically-supported 6-week group CBT-I, adapted from Morin (1993),
63
 comprising 6 
modules: psychoeducation about sleep and circadian rhythms; relaxation; sleep hygiene; stimulus 
control; sleep restriction; and cognitive therapy.
63
 Each group included 4 to 6 participants, for a 
total of 5 CBT-I groups in the present study. A licensed clinical psychologist with training and 
experience in CBT-I  conducted the treatment. Each weekly session lasted 90 minutes.  
Statistical Analysis 
 Independent samples t-tests were first used to compare PSG and spindle variables in 





independent samples t-tests were used to compare drop-outs with those who completed the study 
in order to assess possible differences. Paired t-tests were performed on all outcome measures to 
confirm treatment response as well as on all spindle and EEG measures to confirm group 
stability from pre to post treatment. Additionally, intraclass correlations (ICC) for each spindle 
measure were calculated to assess stability at the individual level a using a single measure, 
absolute agreement, two-way mixed effects model. Finally, to more broadly assess the 
relationship between spindle measures between each other and at both time points, an inter-
correlation matrix of all spindle measures at both time points was created. Additionally, an inter-
correlation matrix of all insomnia outcome measures at both time points was created and ICCs 
were calculated for corresponding measures at each time point, using the same method as above. 
 Multiple regression was used to assess whether baseline spindle density (as well as 
spindle amplitude, power, duration, frequency, and sigma power) predicted the outcome 
measures (PSQI, ISI, sleep efficiency derived from sleep diaries and PSG) at post-treatment, 
when controlling for the same outcome measure at baseline, demographic characteristics (age, 
sex, and education years),  treatment compliance, sleep time in N2, and the location of the 
recording (home versus laboratory). A secondary analysis was performed using delta power as a 
predictor, in order to replicate previous results.
64
 For each outcome measure, a series of multiple 
regressions were performed with the outcome measure at post-treatment as the dependent 
variable and the predictors being added in blocks to the regression model. The first block added 
the same outcome measure at pre-treatment to account for baseline differences, the second block 
added demographic predictors (age, sex, and years of education), the third block added treatment 
compliance as measured by SRAQ scores, the fourth block added N2 duration (to account for the 





fifth block added the location of the recording (to account for possible differences in the 
recordings as a result of some being done at home) and the final block added spindle density (or 
one of the secondary spindle/EGG predictors: duration, amplitude, power, frequency, sigma 
power, delta power, or delta power in first sleep cycle). For each outcome measure, a number of 
regression models were created following this same design with the only difference being what 
spindle/EEG predictor is added in the last block. This allowed each separate spindle measure to 
be tested after controlling for the predictors added in previous blocks, as well as to assess the R
2
 
change from each block of predictors. Coefficients and effect sizes for each predictor are 
reported from the block in which that predictor was added. For instance, values for SRAQ are 
taken from the third block which contains SRAQ, demographics, and baseline. Values for N2 
duration are taken from the fourth block which contains N2 duration, SRAQ, demographics, and 
baseline. Values for spindle density (or other spindle/EEG predictors) were taken from the fifth 
block which contains spindle density, N2 duration, SRAQ, demographics, and baseline.  To 
illustrate the relationships between spindles measures and treatment responses, correlations 
between spindle parameters at pre-treatment and outcome measures following CBT-I were 
calculated using Pearson's product-moment correlation. All results were considered significant at 
p ≤ .05 level. Analyses were conducted with SPSS (IBM, New York, NY, USA)  software. 
RESULTS 
Differences between home and lab recordings 
 Only the first cohort (six participants) were recorded at home for both for pre- and post-
CBT-I recordings. All other cohorts (18 participants in total), had all their recordings done at the 
sleep lab. Independent sample t-tests revealed no significant differences on any spindle measures 





well. In home recordings there was longer sleep latency at post-treatment than in lab recordings 
(t = 2.27, df = 21, p = .034) and in home recordings there was a greater percentage of N2 at both 
pre- (t = 2.13, df = 21, p = .045) and post-treatment (t = 2.11, df = 21, p = .047) than in lab 
recordings (for complete list of means, standard deviations, and mean differences for all 
parameters, see Table 1). These differences are unlikely to have an influence on the overall 
results as differences in N2 are taken into account in the multiple regressions. 
Differences between drop-outs and completers 
 Limited data was available for the few drop-outs in the study with pre-treatment data only 
available for two of the four drop-outs. Independent samples t-tests revealed no significant group 
differences on any spindle, sleep diary or questionnaire measure. There were however some 
differences in PSG measures. The two drop-outs had significantly longer overall sleep duration (t 
= 2.27, df = 24, p = .033), as well as longer N2 duration (t = 2.21, df = 24, p = .037), and shorter 
REM duration (t = 3.27, df = 24. p = .003) and smaller REM percentage (t = 2.56, df = 24, p = 
.017). With limited  data it is hard to draw conclusions about the drop-outs, however the PSG 
differences are unlikely to be biasing as N2 duration is accounted for in the regression models 
and differences in REM and total sleep duration are unlikely to be related to spindles. For 
complete list of means, standard deviations, and mean differences for all parameters, see Table 2. 
Changes in sleep quality after treatment 
 Paired sample t-tests indicated a significant decrease for both PSQI (t = 6.60, df = 23, p = 
.000) and ISI (t = 9.74. df = 23, p = .000) from pre-treatment to post treatment indicating a 
significant improvement in sleep. ISI was reduced on average by 8 points from pre- to post-
treatment (Table 3) which corresponds to an effect size comparable to previous effects reported 
in randomized controlled trials.
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remission (as defined by an ISI score below 8)
65
. For sleep efficiency measures, there was a 
significant increase in sleep efficiency from pre- to post-treatment as measured by sleep diaries (t 
= -3.93, df = 21, p = .001), and trend towards significant increase in sleep efficiency as measured 
by PSG recordings (t = -1.99, df = 22, p = .059).  For means, standard deviations, mean changes 
and complete list of parameters see Table 3. 
Stability of spindle activity following treatment 
 Paired sample t-tests revealed no significant changes at the group level on spindle 
measure from pre- to post-treatment and ICCs confirmed stability at the individual level as well: 
density (t = 0.83, df = 22, p = .418; ICC = 0.81, p = .000), duration (t = 0.51, df =22, p = .615; 
ICC = 0.91, p = .000), amplitude (t = 0.13, df = 22, p = .895; ICC = 0.59, p = .002), power (t = -
0.50, df = 22, p = .960; ICC = 0.71, p = .000), frequency (t = -0.09, df = 22, p = .929; ICC = 
0.80, p = .000), and sigma power (t = -0.03, df = 22, p = .980; ICC = 0.70, p = .000).  This 
indicates that spindle activity is a stable trait not impacted by CBT-I. For means, standard 
deviations and mean changes of all spindle measures, see Table 4. In general, different spindle 
measures tended to highly correlated with one another (except for spindle frequency) and this 
pattern was observed at both time points. In line with the above reported ICCs, each different 
spindle measure at pre-treatment was highly correlated with its corresponding measure at post-
treatment (see Table 5 for complete intercorrelation matrix of all spindle measures at both time 
points). 
Inter-correlations of outcome variables 
 An inter-correlation matrix of outcome variables (PSQI, ISI, sleep diary sleep efficiency 
and PSG sleep efficiency) at both pre- and post-treatment revealed some associations amongst 





(r = -0.51, p = .015), and there was a trend towards a significant positive correlation between 
PSQI and ISI (r = 0.38, p = .067). Interestingly, at post-treatment the outcome measures tend to 
be more correlated with one another, with sleep diary sleep efficiency being negatively 
correlated with both PSQI (r = -0.50, p = .017) and ISI (r = -0.47, p = .029) and a significant 
positive correlation between PSQI and ISI (r = 0.53, p = .008). The negative correlations with 
sleep diary sleep efficiency make sense as higher sleep efficiency implies higher sleep quality 
whereas higher PSQI or ISI implies poorer sleep quality. ICCs revealed a positive association 
between ISI from pre- to post-treatment. See Table 6 for complete inter-correlation matrix of all 
outcome measures at both time points. 
Sleep spindle activity as predictor of treatment response 
Multiple regression assumptions were first checked using normal probability plots to 
confirm normal distribution, standardized residual/predictive value plots to confirm 
homoscedasticity, and variance inflation factors (VIFs) were checked to assess possible 
multicolinearity, with no VIFs exceeding 3.5 and most in the range of 1-2 for variables in all 
models. After using multiple regression controlling for baseline measures, age, sex, education 
years, treatment compliance,  N2 duration, and recording location spindle density and sigma 
power were found to be predictive of treatment outcome. For PSQI, spindle density (B = -2.29, 
SE = 1.07, β = -0.61, t = -2.14, p = .049, adjusted R2 = 0.21, R2 change = 0.16; see Figure 4 for 
scatter plot) and sigma power (B = -86.17, SE = 37.86, β = -0.67, t = -2.28, p = .038, adjusted R2 
= 0.24, R
2
 change = 0.17; see Figure 5 for scatter plot) were inversely related to PSQI at post-
treatment, indicating greater spindle density and sigma power at baseline is predictive of lower 
PSQI scores at post-treatment, indicating better sleep quality (see Table 7 for complete list of 





parameter was found (see Figure 6 for scatter plot of spindle density with ISI), and baseline ISI 
score was found to be predictive of ISI score post treatment (B = 0.70, SE = 0.26, β = 0.50, t = 
2.68, p = .014, adjusted R
2
 = 0.21, R
2
 change = 0.25; see Figure 7 for scatter plot; see Table 8 for 
complete list of coefficients and effect sizes for all ISI predictors). No predictors were related to 
either sleep diary sleep efficiency (see Table 9 for complete list of coefficients and effect sizes 
for all sleep diary sleep efficiency predictors; see Figure 8 for scatter plot of spindle density with 
sleep diary sleep efficiency) or PSG sleep efficiency (see Table 10 for complete list of 
coefficients and effect sizes for all PSG sleep efficiency predictors; see Figure 9 for scatter plot 
of spindle density with PSG sleep efficinecy). Secondary analysis also found no relation between 
delta power at pre-treatment or delta power in the first NREM sleep cycle at pre-treatment and 
any of the outcome measures.   
DISCUSSION 
 These results indicate that subjective sleep quality (as measured by PSQI) after CBT-I 
treatment in chronic insomnia is associated with differences in sleep spindle density and sigma 
power at baseline, above the effects of baseline measures, age, sex, education level, treatment 
adherence, N2 duration, and recording location, although given the large number of regression 
models ran it is possible this result may simply be due to multiple comparisons. This study is 
unique in that it is one of the few to examine the relationship between sleep EEG micro-
architecture and response to treatment in insomnia, and the first to specifically examine spindles 
in this regard. Another distinct advantage to this study is the spindle detection method using 
adapted frequency bands, a method that allows a more accurate measure of spindle parameters as 
it takes into account the individual differences in global spectral profiles, whereas using fixed 





a main weakness of the current study stems from a small sample size, limiting the power of 
statistical tests. However, given the specific exclusion criteria, large time commitment, and the 
necessity of much personal effort needed to complete the study and all its measures in full, it is 
not surprising that the sample was limited and there was some attrition, with four drop-outs over 
the course of the study. The only area where the attrition was an issue was in follow-ups done 
after the therapy which 9 out of the 24 participants did not complete. All 24 participants 
completed the primary portion of the study, focusing on pre- to post-CBT-I effects, although 
some did not complete the 3 month or 1 year follow-ups. The participants who did not complete 
these follow-ups were not considered drop-outs as the primary focus was simply on the pre- to 
post-CBT-I effects. For these reasons, this follow up data was not analyzed here. This is 
unfortunate as with the current analysis conclusions can't be made about the relationship between 
spindles and long term treatment outcomes, although this may be possible with more complex 
statistical methods such as hierarchical linear modeling, which is better suited to deal with 
missing data points. There is also the possibility that the significant results reported here may 
simply be the result of multiple comparisons as a number of regressions were carried out. If a 
Bonferroni adjustment were used, the critical p value would be .002, making the findings no 
longer significant. However the primary spindle variable of interest was density which only 
makes up 4 of the 32 regressions and provides the results of most interest, whereas the other 
regressions focused on secondary spindle predictors that were not the main focus of the study. 
Another weakness of the study is the fact that one of the treatment cohorts had their sleep 
recordings done at home, as opposed to the rest which were done in the sleep lab. This could 
potentially bias the spindle and PSG variables related to the home recordings as sleeping in one's 





less familiar. However, there didn't appear to be any relevant differences in the spindle and PSG 
variables from these recordings, except a higher percentage of N2 in the home recordings at both 
time points. This difference may be related to the fact that in home recordings there tended to be 
less N1 than in lab recordings (although this difference was not statistically significant), 
suggesting that at home it may have been easier for subjects to transition from wake to N2, 
perhaps due to the comfort and familiarity of sleeping at home. However, these differences in N2 
are unlikely to have influenced the results as differences in N2 are accounted for as a predictor in 
the multiple regressions. Despite these weaknesses, this study provides interesting preliminary 
results about the relationship between sleep spindles and treatment outcome in insomnia.  
 Overall, the CBT-I treatment was successful as on average participants improved on self-
reported sleep measures including PSQI, ISI and sleep diary measures of WASO and sleep 
efficiency. Spindle density and sigma power at baseline were predictive only of PSQI with the 
greater magnitude of these spindle characteristics being related to lower PSQI at post-treatment. 
The lack of a spindle effect for ISI is surprising given the findings for the PSQI, and especially 
given the trend for correlation between the two but this may be explained by  a lack of statistical 
power. Likewise, the lack of a predictive effect of spindles on sleep diary may also be due to 
weak statistical power. The absence of any effect for PSG sleep efficiency is not surprising given 
the fairly small change from pre- to post-treatment and a high pre-treatment average (82%). As 
well, PSG measures are  effective at characterizing only the objective aspects of insomnia, such 
as longer sleep latency or night time awakenings, however many sufferers report poor sleep 
quality but may have relatively normal sleep parameters as measured by PSG. Surprisingly, only 
spindle density and sigma power were found to be predictive, despite the fact that both these 





which were not predictive. It may be the case that the most important aspect of spindles for sleep 
stability is their greater occurrence rather than their individual "strengths" so to speak, as 
indicated by longer durations or greater power and amplitude. Given that most previous research 
on spindles and sleep stability have focused on density, this result would seem to make sense. 
Overall, spindles appear to be predictive but it is unclear how universal this may be across 
different kinds of outcome measurements or whether aspects of spindles besides density are 
important.  
 Interestingly, no association was found with delta power at baseline and treatment 
outcomes, contrary to a previous study by Krystal and Edinger.
34
 In the current study, delta 
power was analyzed for all-night NREM sleep (N2-N3) as well as the first sleep cycle (as was 
examined in the previous study), however neither was found to be predictive. This may be due to 
differences in the age range of participants between studies. In the previous study, subjects 
ranged between 40 and 80 years old with an average of 54.9 years, whereas in the present study 
subjects ranged from around 19 to 72 years with an average age of 42.84 years and half of the 
subjects below the age of 40. This is relevant as delta rich slow wave sleep has been noted to 
decrease with age, particularly around 30-40 years.
66
 It may be the case that lower first cycle 
delta power is only predictive in older individuals who as a group already have lower baseline 
delta power than younger individuals. Methodological differences in the spectral analyses may as 
well have contributed to this difference, as the present study used frequency bands adapted for 
each subject based on their global spectral profile whereas the previous study used fixed 
frequency bands for all subjects. 
 Overall, previous work has already shown that lower spindle density may be a 
predisposing factor in developing sleep problems in response to stress
50





indicates that weaker spindle parameters may as well hinder response to CBT-I treatment. Lower 
spindle parameters may be indicative of an innate biological vulnerability to developing and 
perpetuating insomnia. However, it has been noted that spindle measures are not significantly 
different between chronic insomniacs and good sleepers at the group level.
52
 Therefore, it is 
likely that within the population of insomniacs there may be a sub-type of sufferers who 
represent a specific phenotype resistant to CBT-I treatment due to these lower spindle 
parameters. 
 Given previous research on sleep spindles, the most likely  interpretation for why weaker 
spindles might hinder CBT-I treatment is the relationship between spindles and sleep stabiliy. 
Sleep spindles have been associated with the gating of external auditory stimuli during sleep.
43, 44
 
This helps to isolate the cortex from noise that could disrupt sleep and greater spindle density has 
been associated with the ability to maintain stable sleep in the face of noise.
45
 It is possible that 
those participants with weaker spindle traits may simply have more difficulty maintaining stable 
sleep despite their best efforts to incorporate the components of CBT-I and improve their sleep. 
This explanation fits with one of the overarching theories of insomnia, which posits that 
insomniacs are in a psycho-physiological state of hyperarousal.
54
 Weaker spindles may lead to a 
lower arousal threshold during sleep which when combined with other predisposing factors leads 
to the development of an insomnia phenotype resistant to CBT-I. If this is the case, then weaker 
spindles may particularly hinder certain CBT-I components. The most likely candidates are the 
stimulus control and sleep restriction components. Stimulus control seeks to condition the bed 
and bedroom to be less arousing by associating it with only sleep related activity, and 
importantly reducing noise to create a quiet environment conducive to sleep. If spindle 





they may make this conditioning harder to accomplish. As well, sleep restriction seeks to 
consolidate sleep through by setting particular sleep and wake times, leading to partial 
deprivation at first, to drive consolidated sleep on subsequent nights. If spindles are related to the 
general ability to maintain long, stable, consolidated periods of sleep then this too may be 
difficult to accomplish in those with weaker spindles.  
 If weaker spindles do represent a new insomnia subtype this could have important 
clinical implications. These individuals may simply not benefit as much from typical CBT-I as 
other insomnia sufferers and may need more specialized CBT-I that is focused more on stimulus 
control and noise reduction or they be more suited for other forms of intervention such as 
pharmacological intervention. This is of particular note as CBT-I can often be expensive and 
time-consuming and these individuals may become frustrated with a lack of improvement 
leading to a worsening of symptoms. This suggests that insomnia treatment should be more 
individualized and spindle parameters at baseline may be an important factor in recommending 
particular lines of treatment. However, in the current study insomniacs were not able to be 
divided into meaningful groups based on spindle characteristics so the idea of a new subtype is 
tentative.  
 Spindles being of clinical relevance also may point to more novel forms of treatment that 
seek to modify brain oscillations. As noted here spindle parameters did not change in response to 
therapy and previous research has indicated that spindles represent an individual trait that does 
not change significantly from night to night.
48, 49
 This supports our overall hypothesis that lower 
spindle parameters may be a biomarker of poorer response to CBT-I as spindles do not improve 
or change in response to CBT-I. However, it may be possible to alter spindle parameters with 





sleep, there is some evidence that they can be manipulated. Two such approaches that have 
already been used to varying degrees of success in the treatment of insomnia are directly altering 
brain activity with artificial stimulation, such as transcranial magnetic stimulation (TMS), and 
using biofeedback and conditioning to alter brain activity, most often in the frequency range of 
spindles.  
 TMS uses a magnetic coil placed on the scalp to induce a small electrical current in the 
underlying brain tissue, which can have either an excitatory or inhibitory effect depending on the 
stimulation protocol. Much research has been devoted to the use of TMS in treating 
neuropsychiatric disorders, particularly depression and motor disorders with mixed results.
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TMS to treat insomnia is mostly unexplored but it is possible TMS could be used to induce 
spindle activity as a form of therapy. Studies have used TMS
68
 and transcranial direct electrical 
stimulation
69
 (a similar procedure that uses low current delivered via scalp electrodes) to induce 
slow waves in healthy sleeping subjects, which concurrently increased spindle activity. The latter 
study particularly noted an increase in activity in the slow spindle range (8-12 Hz) and an 
increased performance on a verbal memory task after brain stimulation during sleep compared to 
a sham. However, only a single study using repetitive TMS (rTMS) to treat primary insomnia 
has been done.
70
 In this study, 120 patients were recruited who met DSM-IV criteria for chronic 
insomnia as well as PSG criteria related to sleep latency, duration, and efficiency. Patients were 
randomly assigned to undergo treatment for two weeks in one of three groups: rTMS (applied for 
30 min once a day over the dorsolateral prefrontal cortex), psychotherapy (with typical CBT-I 
components), or medication (2 mg estazolam nightly). All participants underwent PSG 
recordings and completed the PSQI before and after treatment. Phone call follow-ups using the 





promising in that participants undergoing rTMS showed improvements on all PSG sleep 
parameters and PSQI, as well as low recurrence rates at follow-up (36%) especially compared 
with the medication group (96%), and therapy group (56%).  However, a major weakness of the 
study is a lack of any kind of control group, particularly a sham TMS condition.  As well, the 
inclusion criteria did not seem to exclude participants with other psychiatric problems, medical 
conditions or screen for additional sleep disorders. Unfortunately, this indicates the results are 
tentative at best. As well, there is no indication of a connection between the rTMS procedure 
used and spindles and the stimulation procedure was quite different than the one previously used 
to induce slow waves and spindles.
68
 It is possible that TMS may be a future form of treatment 
for insomnia, but much more research is required to determine its efficacy and whether its 
therapeutic effect (if any) is related to spindles. 
 Another approach to insomnia treatment instead uses biofeedback and conditioning to 
increase activity in the frequency band of spindles. This is done by conditioning the sensorimotor 
rhythm (SMR), an EEG oscillation recorded predominately over the sensorimotor cortex in 
waking with a range of around 12-15 Hz (similar to that of spindles). One of the earliest studies 
on the SMR in cats demonstrated that instrumental conditioning reinforcing the SMR during 
wake led to an increase in spindle activity during sleep as well as longer epochs of undisturbed 
sleep.
41
 SMR conditioning was later applied to insomniacs along with another biofeedback 
protocol focusing on relaxation therapy achieved through EMG-theta feedback, and it was found 
that both these methods improvement sleep quality to some extent, although this improvement 
was only observed in home sleep diaries, not in laboratory PSG recordings, and these studies 
were conducted before development of standardized questionnaires like the PSQI and ISI.
71, 72
 





type of biofeedback training was most effective. Insomniacs with high psychological or muscular 
tension before treatment responded best to EMG-theta feedback while those who were relaxed 
but still reported sleep problems pre-treatment responded better to SMR conditioning. However, 
these early studies lacked control conditions and didn't report whether actual changes in sleep 
EEG were observed after training. Later more comprehensive studies in both healthy sleepers
73
, 
as well as insomniacs
74
, showed that SMR conditioning improved sleep quality measures, 
enhanced sleep spindles, and improved overnight memory consolidation, although these latter 
two effects were much less pronounced and robust in insomniacs. Although the ability to alter 
spindles may be at odds with previous observations of individual spindle stability, biofeedback 
conditioning may prove to be a useful, cost-effective treatment for insomnia in the future, but 
further work is necessary to validate its effects. 
 A final possibility for enhancing sleep spindles with outside intervention is through 
pharmacological means. Little research has been done in this area outside of investigations of 
prescription hypnotic agents already used to treat insomnia. Increase of spindle activity has been 




, and non-benzodiazepine hypnotics
78, 79
.  
Melatonin supplements have as well been noted to increase spindle activity,
80
 but their use in 
treating chronic insomnia lacks conclusive evidence.
81
 Unfortunately, it is impossible to untangle 
the spindle promoting effect of these drugs from the other sleep-promoting effects and remains to 
be seen if more spindle specific compounds are ever discovered. 
 In summary,  sleep spindle density and sigma power at baseline before beginning CBT-I  
may be predictive of whom will respond to this form of treatment, as measured by PSQI. These 
spindle differences within the population of chronic insomniacs may be an endogenous 





algorithms for insomnia treatment, which should be tailored based on individual differences. 
Future research should seek to elucidate the mechanistic interaction between spindles and poor 
CBT-I response, as well as evaluate which therapeutic interventions would be most effective for 
this population, including the investigation of newer techniques aimed at altering brain 
























FIGURES AND TABLES 
 
Figure 1: A schematic representation of the course of the study indicating at what time points 




































Figure 2: Pairs of sleep spindles in 31 year old female participant with high average spindle measures. Density = 2.76 per 30 sec 
epoch; Duration = 1.02 sec; Amplitude = 19.70 µV; Power = 107.90 µV
2
; Sigma power = 0.10 µV
2












Figure 3: Sleep spindle in 72 year old female participant with low average spindle measures. Density = 0.16 per 30 sec epoch; 


















































Table 1: Spindle and PSG measures of participants in cohort 1(ambulatory home 
recordings; N = 6, 4 females) and cohorts 2-5 (sleep lab recordings, N = 18; 15 females) 
compared by independent samples t-test for both pre- and post-treatment. Sigma and 









t value p value 
Pre Spindle Density 
(num per 30 sec 
epoch) 
1.12 (0.33) 1.37 (0.75) 0.25 -0.77 .450 
Pre Spindle Duration 
(sec) 
0.85 (0.03) 0.89 (0.13) 0.04 -1.29 .212 
Pre Spindle 
Amplitude (µV) 
7.2 (1.69) 10.51 (4.11) 3.31 -1.90 .071 
 Pre Spindle Power 
(µV2) 
14.15 (6.08) 33.68 (25.28) 19.53 -1.85 .078 
Pre Spindle 
Frequency (Hz) 
13.88 (0.28) 13.85 (0.39) -0.03 0.19 .850 
Pre Sigma Power 
(µV2 per 30 sec 
epoch) 
0.06 (0.01) 0.06 (0.02) 0 -0.57 .576 
Pre Delta Power (µV2 
per 30 sec epoch) 
0.53 (0.05) 0.50 (0.05) -0.03 1.44 .164 
Pre Delta power in 
first sleep cycle (µV2) 
0.54 (0.07) 0.54 (0.10) 0 -0.12 .907 
Pre PSG sleep 
efficiency (%) 
89.02 (4.32) 78.39 (13.20) -10.63 1.91 .069 
Pre PSG WASO (min) 32.70 (20.83) 86.28 (69.18) 53.58 -1.85 .079 
Pre PSG sleep 
latency (min) 
21.60 (21.57) 20.09 (16.31) -1.51 0.18 .858 
Pre PSG TST (min) 381.50 (25.56) 377.08 (65.42) -4.42 0.16 .875 
Pre PSG N1 % of TST 4.47 (2.15) 12.24 (10.53) 7.77 -1.77 .091 
Pre PSG N1 Duration 
(min) 
16.67 (7.33) 45.53 (40.84) 28.86 -1.70 .104 
Pre PSG N2 % of TST 67.62 (7.95) 59.33 (8.36) -8.29 2.13 .045* 
Pre PSG N2 Duration 
(min) 
256.50 (25.58) 222.81 (40.77) -33.69 1.89 .072 
Pre PSG N3 % of TST 7.60 (9.56) 10.12 (6.35) 2.52 -0.74 .467 
Pre PSG N3 Duration 
(min) 
30.33 (40.72) 40.08 (26.76) 9.75 -0.68 .505 
Pre PSG REM % of 
TST 
20.45 (2.41) 17.87 (4.90) -2.58 1.23 .232 
Pre PSG REM 
Duration (min) 
78.08 (11.02) 70.17 (23.85) -7.91 0.78 .446 
Post Spindle Density 
(num per 30 sec 








0.89 (0.03) 0.87 (0.11) -0.02 0.53 .605 
Post Spindle 
Amplitude (µV) 
8.32 (2.26) 10.54 (4.29) 2.22 -1.20 .244 
Post Spindle Power 
(µV2) 
19.75 (9.71) 33.93 (28.13) 14.18 -1.19 .246 
Post Spindle 
Frequency (Hz) 
13.88 (0.21) 13.86 (0.39) -0.02 0.15 .886 
Post Sigma Power 
(µV2 per 30 sec 
epoch) 
0.07 (0.02) 0.06 (0.02) -0.01 1.42 .170 
Post PSG sleep 
efficiency (%) 
88.52 (8.12) 86.92 (8.29) -1.6 0.41 .687 
Post PSG WASO 
(min) 
29.58 (25.25) 45.58 (33.05) 16 -1.07 .295 
Post PSG sleep 
latency (min) 
19.30 (8.61) 10.24 (8.37) -9.06 2.27 .034* 
Post PSG TST (min) 405.67 (90.31) 371.87 (66.72) -33.8 0.96 .341 
Post PSG N1 % of 
TST 
5.00 (4.09) 8.01 (5.60) 3.01 -1.20 .244 
Post PSG N1 
Duration (min) 
18.25 (10.80) 29.68 (21.78) 11.43 -1.22 .236 
Post PSG N2 % of 
TST 
68.25 (6.32) 60.04 (8.68) -8.21 2.11 .047* 
Post PSG N2 
Duration (min) 
270.17 (45.20) 225.32 (51.68) -44.85 1.88 .074 
Post PSG N3 % of 
TST 
7.52 (4.45) 11.70 (7.45) 4.18 -1.29 .213 
Post PSG N3 
Duration (min) 
30.33 (18.90) 42.47 (26.06) 12.14 -1.04 .310 
Post PSG REM % of 
TST 
20.23 (6.99) 19.14 (5.78) -1.09 0.38 .708 
Post PSG REM 
Duration (min) 
87.00 (47.41) 72.94 (28.36) -14.06 0.87 .392 
PSG, polysomnography; WASO, wake after sleep onset; TST, total sleep time 
















Table 2: Insomnia outcome, PSG, and spindle measures of participants who dropped 
out for which data was available (N = 2; 2 females) compared to participants who 
completed the study (N = 24; 19 females). Sigma and delta power values are 









t value p value 
PSQI 10.00 (7.07) 10.91 (3.52) 0.91 -0.39 .698 
ISI 21.50 (7.78) 15.91 (3.13) -5.59 1.03 .487 
SLD sleep 
efficiency (%) 
56.62 (39.94) 72.21 (12.45) 15.59 -0.55 .679 
SLD WASO 
(min) 
133.21 (151.02) 55.59 (40.08) -77.62 0.73 .600 
SLD sleep 
latency (min) 
41.86 (29.90) 48.42 (40.95) 6.56 -0.29 .812 
SLD sleep 
duration (min) 
325.00 (247.49) 348.20 (81.69) 23.2 -0.13 .916 
PSG sleep 
efficiency (%) 
91.85 (4.31) 82.43 (10.69) -9.42 1.20 .241 
PSG WASO 
(min) 
35.90 (19.66) 67.49 (60.44) 31.59 -0.79 .437 
PSG sleep 
latency (min) 
7.45 (1.77) 20.82 (17.57) 13.37 -1.05 .306 
PSG TST (min) 472.25 (12.37) 385.76 (44.95) -86.49 2.27 .033* 
PSG N1 % of 
TST 
4.05 (1.20) 9.77 (9.59) 5.72 -0.89 .382 
PSG N1 
Duration (min) 
19.00 (4.95) 37.98 (38.32) 18.98 -0.72 .482 
PSG N2 % of 
TST 
62.50 (3.96) 61.38 (9.08) -1.12 0.13 .899 
PSG N2 
Duration (min) 
294.75 (10.96) 235.78 (33.84) -58.97 2.21 .037* 
PSG N3 % of 
TST 
7.50 (4.67) 9.80 (7.12) 2.30 -0.34 .741 
PSG N3 
Duration (min) 
35.75 (22.98) 38.89 (30.18) 3.14 -0.05 .961 
PSG REM % of 
TST 
26.00 (0.42) 19.07 (3.65) -6.93 2.56 .017* 
PSG REM 
Duration (min) 
122.75 (5.30) 74.30 (19.06) -48.45 3.27  .003** 
Pre Spindle 
Density (num 
per 30 sec 
epoch) 
1.00 (0.13) 1.27 (0.67) 0.27 -0.64 .531 
Pre Spindle 
Duration (sec) 
0.90 (0.13) 0.88 (0.11) -0.02 0.20 .844 
Pre Spindle 
Amplitude (µV) 







38.60 (1.13) 30.03 (23.28) -8.57 0.58 .569 
Pre Spindle 
Frequency (Hz) 
13.70 (0.14) 13.86 (0.37) 0.16 -0.61 .551 
Pre Sigma 
Power (µV2 per 
30 sec epoch) 
0.05 (0.01) 0.06 (0.02) 0.01 -0.61 .545 
PSQI, Pittsburgh Sleep Quality Index; ISI, Insomnia Severity Index; WASO, wake after 
sleep onset; SLD, sleep diary; PSG, polysomnography; TST, total sleep time 








































Table 3: Demographic characteristics and sleep measures of participants at baseline 
(pre-treatment) and immediately after CBT-I (post-treatment) (N = 24, 19 females; N = 









t value p value 
Age 42.84 (15.7) - - - - 
Education 
years 
16 (3.09) - - - - 
Insomnia 
duration years 
14.76 (15.70) - - - - 
PSQI 10.91 (3.52) 5.83 (2.55) -5.08 6.60 .000** 
ISI 15.91 (3.13) 8.17 (4.51) -7.74 9.74 .000** 
SLD sleep 
efficiency (%) 
72.21 (12.45) 84.8 (10.61) 12.59** -3.93 .001** 
SLD WASO 
(min) 
55.59 (40.08) 25 (22.93) -30.59** 3.28 .004** 
SLD sleep 
latency (min) 
48.42 (40.95) 19.59 (15.27) -28.83** 3.12 .005** 
SLD sleep 
duration (min) 
348.2 (81.69) 382.52 (60.18) 34.32 -1.82 .083 
PSG sleep 
efficiency (%) 
82.43 (10.69) 87.34 (8.09) 4.91 -1.99 .059 
PSG WASO 
(min) 
67.49 (60.44) 41.4 (31.49) -26.09 2.29 .032* 
PSG sleep 
latency (min) 
20.82 (17.57) 12.6 (9.19) -8.22 2.11 .046* 
PSG TST (min) 385.76 (44.95) 380.68 (72.95) -5.08 0.30 .770 
PSG N1 % of 
TST 
9.77 (9.59) 7.22 (5.33) -2.55 1.71 .102 
PSG N1 
Duration (min) 
37.98 (38.32) 26.70 (19.95) -11.28 1.87 .075 
PSG N2 % of 
TST 
61.38 (9.08) 62.18 (8.8) 0.8 -0.56 .580 
PSG N2 
Duration (min) 
235.78 (33.84) 237.02 (53.03) 1.24 -0.12 .916 
PSG N3 % of 
TST 
9.8 (7.12) 10.61 (6.96) 0.81 -0.47 .646 
PSG N3 
Duration (min) 
38.89 (30.18) 39.30 (24.59) 0.41 -0.07 .946 
PSG REM % of 
TST 
19.07 (3.65) 19.42 (5.97) 0.35 2.02 .763 
PSG REM 
Duration (min) 
74.30 (19.06) 76.61 (33.70) 2.31 -0.31 .758 
PSQI, Pittsburgh Sleep Quality Index; ISI, Insomnia Severity Index; WASO, wake after 
sleep onset; SLD, sleep diary; PSG, polysomnography; TST, total sleep time 






Table 4: Spindle measures of participants at pre- and post-treatment. Sigma power 









t value p value 
Spindle Density 
(num per 30 sec 
epoch) 
1.27 (0.67) 1.20 (0.68) -0.07 0.83 .418 
Spindle Duration 
(sec) 
0.88 (0.11) 0.88 (0.10) 0 0.51 .615 
Spindle Amplitude 
(µV) 
10.05 (3.54) 9.96 (3.94) -0.09 0.13 .895 
Spindle Power 
(µV2) 
30.03 (23.28) 30.23 (25.25) 0.20 -0.05 .960 
Spindle 
Frequency (Hz) 
13.86 (0.37) 13.87 (0.34) 0.01 -0.09 .929 
Sigma Power (µV2 
per 30 sec epoch) 
0.06 (0.02) 0.06 (0.02) 0 -0.03 .980 






























Table 5: Inter-correlation matrix for all spindle measures pre- and post-treatment, intra-class correlations are presented 
for corresponding measures at pre/post (bolded cells) 
 


























Density   
(Pre) 
Pearson's r 1            
p value              
Duration 
(Pre) 
Pearson's r .803** 1           
p value .000             
Amplitude 
(Pre) 
Pearson's r .448* .595** 1          
p value .028 .002            
Power     
(Pre) 
Pearson's r .575** .614** .953** 1         
p value .003 .001 .000           
Frequency 
(Pre) 
Pearson's r -.067 -.210 -.130 -.147 1        
p value .755 .324 .545 .493          
Sigma 
Power (Pre) 
Pearson's r .949** .790** .381 .481* -.160 1       
p value .000 .000 .066 .017 .455         
Density 
(Post) 
Pearson's r .811** .613** .347 .442* .106 .773** 1      
p value .000 .002 .105 .035 .630 .000        
Duration 
(Post) 
Pearson's r .786** .911** .362 .397 -.159 .761** .705** 1     
p value .000 .000 .090 .061 .469 .000 .000       
Amplitude 
(Post) 
Pearson's r .495* .426* .586** .580** .115 .374 .384 .346 1    
p value .016 .043 .002 .004 .601 .079 .070 .106      
Power   
(Post) 
Pearson's r .546** .421* .672** .714** .060 .443* .421* .314 .955** 1   
p value .007 .046 .000 .000 .785 .034 .046 .145 .000     
Frequency 
(Post) 
Pearson's r -.042 -.112 -.035 -.029 .797** -.117 .123 -.038 .031 .022 1  




Pearson's r .659** .473* .156 .222 .039 .699** .831** .572** .423* .445* .049 1 
p value .001 .023 .478 .309 .859 .000 .000 .004 .045 .034 .825   
 






Table 6: Inter-correlation matrix of all outcome measures at pre- and post-treatment, intra-class correlations are 
presented for corresponding measures at pre/post (bolded cells) 
 


























       
p value 





      
p value .067 







-.512* -.264 1 
     
p value .015 .236 






-.329 -.358 .085 1 
    
p value .117 .086 .708 




.072 .094 -.020 -.304 1 
   
p value .197 .661 .930 .148 




.122 .151** -.040 -.194 .532** 1 
  
p value .569 .009 .861 .363 .008 







-.299 -.145 .100 .275 -.503* -.465* 1 
 







.015 -.024 .031 .201 -.165 -.085 .240 1 
p value .948 .913 .891 .150 .453 .700 .282 
 
**Significant at p≤0.01 








Table 7: Coefficients and effect sizes for predictors in the multiple regressions with PSQI as outcome measure. 
Coefficients and effect sizes for each predictor are taken from the block of the regression in which that predictor is 
entered. Each spindle/EEG predictor represents a separate regression. (N = 24, 19 females) *Significant at p≤0.05 
 Predictors Post CBT-I PSQI  
Model 
 










1 Pre CBT-I PSQI 0.13 0.15 0.19 0.90 .377 -0.01 0.04 0.81 .377 0.04 
2 
Sex -0.73 1.35 -0.12 -0.54 .597 
-0.04 0.12 0.79 .514 
0.01 
Age 0.01 0.04 0.08 0.34 .740 0.01 
Education 
years 
-0.22 0.19 -0.28 -1.19 .249 0.07 




0.00 0.02 0.00 0.01 .990 -0.03 0.00 0.00 .990 0.00 
5 Home vs. lab -2.33 1.59 -0.41 -1.46 .162 0.04 0.09 2.14 .162 0.09 








-0.23 0.21 -0.36 -1.08 .297 0.05 0.05 1.17 .297 0.05 




1.18 1.69 0.17 0.70 .496 0.00 0.02 0.49 .496 0.02 
6 Sigma power -86.17 37.86 -0.67 -2.28 .038* 0.24 0.17 5.18 .038* 0.17 
6 Delta Power 2.45 14.48 0.05 0.17 .868 -0.03 0.00 0.03 .868 0.00 
6 
Delta Power in 
first sleep cycle 





Table 8: Coefficients and effect sizes for predictors in the multiple regressions with ISI as outcome measure. Coefficients 
and effect sizes for each predictor are taken from the block of the regression in which that predictor is entered. Each 
spindle/EEG predictor represents a separate regression. (N = 24, 19 females) *Significant at p≤0.05 
 Predictors Post CBT-I ISI  














Sex -1.28 2.31 -0.12 -0.56 .585 
0.13 0.04 0.31 .821 
0.01 
Age -0.01 0.06 -0.05 -0.24 .813 0.00 
Education 
years 
-0.18 0.30 -0.13 -0.59 .563 0.01 




0.04 0.03 0.33 1.15 .265 0.24 0.04 1.33 .265 0.04 
5 Home vs. lab -1.85 2.56 -0.19 -0.72 .479 0.22 0.02 0.53 .479 0.02 








-0.10 0.36 -0.09 -0.29 .777 0.17 0.00 0.08 .777 0.00 




-1.42 2.76 -0.12 -0.51 .615 0.18 0.01 0.26 .615 0.01 
6 Sigma power 25.34 65.29 0.11 0.39 .703 0.17 0.01 0.15 .703 0.01 
6 Delta Power 22.40 22.99 0.26 0.97 .345 0.22 0.03 0.95 .345 0.03 
6 
Delta Power in 
first sleep cycle 





Table 9: Coefficients and effect sizes for predictors in the multiple regressions with sleep diary sleep efficiency as 
outcome measure. Coefficients and effect sizes for each predictor are taken from the block of the regression in which that 
predictor is entered. Each spindle/EEG predictor represents a separate regression. (N = 22, 19 females) 
 Predictors Post CBT-I SD Sleep Efficiency  











Pre CBT-I  SD 
Sleep Efficiency 
0.13 0.19 0.16 0.71 .486 -0.02 0.03 0.50 .486 0.03 
2 
Sex -4.24 7.09 -0.16 -0.60 .558 
-0.12 0.07 0.44 .731 
0.02 
Age -0.17 0.17 -0.26 -1.03 .319 0.06 
Education 
years 
0.33 0.81 0.10 0.40 .692 0.01 




0.01 0.09 0.02 0.07 .945 -0.06 0.00 0.01 .945 0.00 
5 Home vs. lab -2.76 7.61 -0.12 -0.36 .722 -0.12 0.01 0.13 .722 0.01 








0.10 1.29 0.03 0.07 .943 -0.21 0.00 0.01 .943 0.00 




-11.38 8.06 -0.40 -1.41 .181 -0.05 0.10 1.99 .181 0.10 
6 Sigma power 331.18 190.77 0.61 1.74 .106 0.02 0.14 3.01 .106 0.14 
6 Delta Power -75.25 75.88 -0.37 -0.99 .339 -0.12 0.05 0.98 .339 0.05 
6 
Delta Power in 
first sleep cycle 





Table 10: Coefficients and effect sizes for predictors in the multiple regressions with PSG sleep efficiency as outcome 
measure. Coefficients and effect sizes for each predictor are taken from the block of the regression in which that predictor 
is entered. Each spindle/EEG predictor represents a separate regression. (N = 24, 19 females) 
 Predictors Post CBT-I PSG Sleep Efficiency  











Pre CBT-I PSG 
Sleep Efficiency 
0.17 0.16 0.23 1.08 .292 0.01 0.05 1.17 .292 0.05 
2 
Sex -5.70 5.15 -0.27 -1.12 .283 
-0.07 0.07 0.50 .668 
0.06 
Age -0.08 0.14 -0.16 -0.60 .557 0.02 
Education 
years 
-0.04 0.63 -0.02 -0.07 .945 .0.00 




0.05 0.08 0.20 0.58 .573 -0.16 0.02 0.33 .573 0.02 
5 Home vs. lab 1.03 5.74 0.06 0.18 .860 -0.24 0.00 -0.03 .860 0.00 








0.64 1.02 0.28 0.62 .543 -0.29 0.02 0.39 .543 0.02 




-8.66 6.44 -0.40 -1.34 .200 -0.17 0.10 1.81 .200 0.10 
6 Sigma power 177.39 147.84 0.43 1.20 .250 -0.20 0.08 1.44 .250 0.08 
6 Delta Power -5.80 52.21 -0.04 -0.11 .913 -0.32 0.00 0.01 .913 0.00 
6 
Delta Power in 
first sleep cycle 
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